In vitro response of cervical cancer cell lines CaSki, HeLa, and ME-180 to the antiestrogen tamoxifen

This publication has 37 references indexed in Scilit:

• Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle
  European Journal of Cancer and Clinical Oncology, 1983
• Treatment of carcinoma of the cervix with bromocriptine
  BJOG: An International Journal of Obstetrics and Gynaecology, 1982
• Advanced ovarian carcinoma: Response to antiestrogen therapy
  Cancer, 1981
• Tamoxifen as a possible chemotherapeutic agent in endometrial adenocarcinoma
  Gynecologic Oncology, 1981
• Endometrial Carcinoma Insensitive to Progestin and Cytotoxic Chemotherapy May Respond to Tamoxifen
  Acta Obstetricia et Gynecologica Scandinavica, 1981
• The use of antiestrogens tamoxifen and nafoxidine in the treatment of human breast cancer in correlation with estrogen receptor values.A phase II study
  Cancer, 1978
• Tumor Antigen and Human Chorionic Gonadotropin in CaSki Cells: A New Epidermoid Cervical Cancer Cell Line
  Science, 1977
• MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors
  Steroids, 1975
• A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2
  JNCI Journal of the National Cancer Institute, 1973
• A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474
  British Journal of Cancer, 1971